Search results for "ZOL"

showing 10 items of 4792 documents

Clinical experience of lomitapide therapy in patients with homozygous familial hypercholesterolaemia.

2014

The microsomal triglyceride transfer protein (MTP) inhibitor lomitapide is a licenced adjunct to a low-fat diet and other lipid-lowering medication, with or without low-density lipoprotein apheresis, for the treatment of adults with homozygous familial hypercholesterolaemia (HoFH). In a recently published phase 3 study, patients with HoFH received lomitapide in addition to maximally tolerated lipid-lowering therapy. Treatment with lomitapide resulted in a mean approximate 50% reduction in LDL-C levels after 26 weeks compared with baseline levels (p < 0.0001). This decrease in LDL-C was maintained at Weeks 56 and 78 (44% [p < 0.0001] and 38% [p = 0.0001], respectively). This paper offers cli…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaPhases of clinical researchMicrosomal triglyceride transfer proteinHyperlipoproteinemia Type IIchemistry.chemical_compoundYoung AdultInternal medicineHo-FH lomitapide MTPInternal MedicinemedicineEffective treatmentHumansIn patientAdverse effectbiologymedicine.diagnostic_testbusiness.industryAnticholesteremic AgentsHomozygoteGeneral MedicineCholesterol LDLMiddle AgedLomitapideEndocrinologyApheresisTreatment Outcomechemistrybiology.proteinBenzimidazolesFemaleCardiology and Cardiovascular MedicinebusinessLiver function testsAtherosclerosis. Supplements
researchProduct

Clonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skin

2005

Sustained sympathetic activation not only leads to vasoconstriction but also might induce paradox vasodilation. This study was performed to explore whether and how alpha(2)-receptor stimulation mediates this vasodilation. We investigated 11 healthy subjects in 33 dermal microdialysis (MD) sessions. After nerve trunk blockade, MD fibers were inserted and perfused with physiological saline until skin trauma-related vasodilation subsided. Thereafter, fibers were perfused with either clonidine solutions (10(-3), 5 x 10(-4), 10(-4) mol/l), N(G)-monomethyl-l-arginine (L-NMMA; nitric oxide synthase blocker), acetylsalicylic acid (ASA; cyclooxygenase blocker), or combinations of these. Laser-Dopple…

AdultMalemedicine.medical_specialtySympathetic nervous systemPhysiologyImidazoline receptorProstaglandinVasodilationStimulationNitric OxideClonidineNitric oxidechemistry.chemical_compoundReference ValuesSkin Physiological PhenomenaPhysiology (medical)Internal medicineAdrenergic alpha-2 Receptor AgonistsmedicineHumansSkinDose-Response Relationship DrugChemistryVasodilationEndocrinologymedicine.anatomical_structureEicosanoidProstaglandinsmedicine.symptomAdrenergic alpha-AgonistsBlood Flow VelocityVasoconstrictionJournal of Applied Physiology
researchProduct

Effects of Nebivolol versus Carvedilol on Left Ventricular Function in Patients with Chronic Heart Failure and Reduced Left Ventricular Systolic Func…

2006

Beta-adrenoceptor antagonist (beta-blocker) therapy results in a significant improvement in left ventricular (LV) systolic function and prognosis in patients with chronic heart failure. Both carvedilol and nebivolol produce hemodynamic and clinical benefits in chronic heart failure, but it is unknown whether their peculiar pharmacologic properties produce different effects on LV function.To assess the effects on LV function of nebivolol compared with carvedilol in patients with chronic heart failure and reduced LV systolic function.Seventy patients with a LV ejection fractionor=40% and in New York Heart Association (NYHA) functional class II or III were randomly assigned to receive carvedil…

AdultMalemedicine.medical_specialtySystoleAdrenergic beta-AntagonistsCarbazolesHemodynamicsVentricular Function LeftNebivololPropanolaminesElectrocardiographyHeart RateInternal medicineHeart rateHumansMedicineBenzopyransPharmacology (medical)SystoleCarvedilolAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseNebivololEthanolaminesHeart failureCardiologyCarvedilolFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographymedicine.drugAmerican Journal of Cardiovascular Drugs
researchProduct

Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone p…

2018

BACKGROUND Long-acting injectable (LAI) antipsychotics can improve medication adherence and reduce hospitalisation rates compared with oral treatments. Paliperidone palmitate (PAL) and aripiprazole monohydrate (ARI) LAI treatments were associated with improvements in global functioning in patients with schizophrenia. OBJECTIVE The objective of this study was to assess the predictive factors of better overall functioning in patients with chronic schizophrenia and schizoaffective disorder treated with PAL and ARI. METHOD Enrolled were 143 (97 males, 46 females, mean age 38.24 years, SD = 12.65) patients with a diagnosis of schizophrenia or schizoaffective disorder, whom we allocated in two gr…

AdultMalemedicine.medical_specialtyaripiprazole monohydrate; global assessment of functioning; long-acting injectable antipsychotics; paliperidone palmitate; schizoaffective disorder; schizophrenia; neurology; neurology (clinical); psychiatry and mental health; pharmacology (medical)Global Assessment of FunctioningAripiprazoleSchizoaffective disorderPharmacyOutcome Assessment (Health Care)03 medical and health sciencesYoung Adult0302 clinical medicineglobal assessment of functioningInternal medicineOutcome Assessment Health CarePaliperidone PalmitatemedicineHumansPharmacology (medical)aripiprazole monohydratearipiprazole monohydrate; global assessment of functioning; long-acting injectable antipsychotics; paliperidone palmitate; schizoaffective disorder; schizophrenia; Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Schizophrenia; Young Adult; Outcome Assessment (Health Care)Paliperidone Palmitatebusiness.industrylong-acting injectable antipsychoticsMiddle Agedschizoaffective disordermedicine.disease030227 psychiatryPsychiatry and Mental healthNeurologyPsychotic DisordersSchizophreniaDelayed-Action PreparationsSettore SECS-P/03 - Scienza delle FinanzeSchizophreniaChronic schizophreniaAripiprazoleFemaleNeurology (clinical)business030217 neurology & neurosurgeryDiagnosis of schizophreniamedicine.drugAntipsychotic AgentsHuman psychopharmacology
researchProduct

Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus

2010

The aim of the present study was to compare the effect of PIO (pioglitazone) or GLIM (glimepiride) on erythrocyte deformability in T2DM (Type 2 diabetes mellitus). The study covered 23 metformin-treated T2DM patients with an HbA1c (glycated haemoglobin) &amp;gt;6.5%. Patients were randomized to receive either PIO (15 mg, twice a day) or GLIM (1 mg, twice a day) in combination with metformin (850 mg, twice a day) for 6 months. Blood samples were taken for the measurement of fasting glucose, HbA1c, fasting insulin, intact proinsulin, adiponectin and Hct (haematocrit). In addition, the erythrocyte EI (elongation index) was measured using laser diffractoscopy. Both treatments significantly impr…

AdultMalemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentType 2 diabetesInsulin resistanceErythrocyte DeformabilityInternal medicineDiabetes mellitusHumansHypoglycemic AgentsMedicineAgedProinsulinGlycated HemoglobinPioglitazoneAdiponectinbusiness.industryInsulinnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseMetforminGlimepirideSulfonylurea CompoundsEndocrinologyDiabetes Mellitus Type 2Drug Therapy CombinationFemaleThiazolidinedionesStress MechanicalbusinessPioglitazonemedicine.drugClinical Science
researchProduct

Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics

1997

AdultMalemedicine.medical_specialtyglossitiGlossitismedicine.drug_classAntibioticsadverse drug reactionLansoprazole2-PyridinylmethylsulfinylbenzimidazolesGlossitisPharmacotherapyTongueClarithromycinClarithromycinmedicineAdverse Drug Reaction Reporting SystemsHumansPharmacology (medical)StomatitisAgedStomatitisbusiness.industryMiddle AgedAnti-Ulcer Agentsmedicine.diseaselansoprazoleDermatologyAnti-Bacterial Agentsmedicine.anatomical_structureDrug Therapy CombinationFemalebusinessclarythromicinOmeprazoleAdverse drug reactionmedicine.drug
researchProduct

Ciclosporin and thyroid-stimulating immunoglobulins in endocrine orbitopathy.

1989

The study investigated whether ciclosporin (C) affected the thyroid-stimulating immunoglobulins (TSI) in serum of patients with endocrine orbitopathy (EO). The effect of C was compared with that of prednisone (P). Fifteen patients with EO classes III-V received C (n = 7) or P (n = 8). In addition to the immunosuppressants, five patients with Graves' disease in each group received methimazole (MMI). The stimulation of the cAMP levels in the medium of thyrocyte cultures was determined as a parameter of TSI. The TSI levels were markedly lowered in both groups during and after therapy. C group: before therapy 6.2 pmol/ml +/- 1.63 (100%, mean +/- SEM), during treatment 4.6 pmol/ml +/- 2.28 (74%)…

AdultMalemedicine.medical_specialtymedicine.drug_classGraves' diseasemedicine.medical_treatmentThyroid GlandCyclosporinsPrednisoneInternal medicinemedicineCyclic AMPExophthalmosHumansAgedChemotherapyTriiodothyronineMethimazolebusiness.industryThyroidGeneral MedicineMiddle Agedmedicine.diseaseCiclosporinGraves DiseaseTiterEndocrinologymedicine.anatomical_structureImmunoglobulin GCorticosteroidPrednisoneTriiodothyronineFemalebusinessmedicine.drugImmunoglobulins Thyroid-StimulatingResearch in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie
researchProduct

Effect of intravenous application of esomeprazole 40???mg versus pantoprazole 40???mg on 24-hour intragastric pH in healthy adults

2007

BACKGROUND: It has been demonstrated that therapy with proton pump inhibitors reduces recurrence of bleeding following initial endoscopic treatment of bleeding peptic ulcers. AIM: This study compared the effects of esomeprazole 40 mg and pantoprazole 40 mg on intragastric acid control. Both substances were administered intravenously as 15-min infusion and as bolus injection. METHODS: Healthy men and women volunteers were enrolled in this single-center, open, randomized, three-way crossover study. After administration of esomeprazole 40 mg and pantoprazole 40 mg intravenously as 15-min infusion, and pantoprazole 40 mg intravenously as bolus injection, continuous 24-h intragastric pH monitori…

AdultMalemedicine.medical_specialtymedicine.drug_classPepticProton-pump inhibitorPharmacologyGastroenterology2-PyridinylmethylsulfinylbenzimidazolesHelicobacter InfectionsEsomeprazoleGastric AcidInternal medicineHumansMedicineEsomeprazole SodiumInfusions IntravenousPantoprazoleMonitoring PhysiologicPantoprazoleCross-Over StudiesHelicobacter pyloriHepatologybusiness.industryStomachGastroenterologyEsomeprazoleGastric Acidity DeterminationHydrogen-Ion ConcentrationMiddle AgedAnti-Ulcer AgentsCrossover studymedicine.anatomical_structureInjections IntravenousBody ConstitutionGastric acidFemalebusinessmedicine.drugEuropean Journal of Gastroenterology &amp; Hepatology
researchProduct

The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.

1996

BACKGROUND: The combination of omeprazole with amoxycillin or clarithromycin is used as treatment against Helicobacter pylori. It seems likely that the antibacterial activity of the antibiotic may be improved by increasing gastric pH towards neutrality, and a twice daily regimen of omeprazole is probably needed. AIM: To assess the effects of twice daily administration of omeprazole 20 and 40 mg. METHODS: Twelve duodenal ulcer patients in remission were randomized to receive in single-blind fashion either placebo, omeprazole 20 mg or omeprazole 40 mg twice daily (08.00 and 20.00 h). On the sixth day of dosing they underwent 24-h gastric pH-metry. RESULTS: Omeprazole 20 and 40 mg b.d. produce…

AdultMalemedicine.medical_specialtymedicine.drug_classProton-pump inhibitorGastroenterologyHelicobacter InfectionsGastric AcidInternal medicineClarithromycinmedicineHumansSingle-Blind MethodPharmacology (medical)Enzyme InhibitorsOmeprazoleGastric Acidity DeterminationCross-Over StudiesHelicobacter pyloriHepatologybiologybusiness.industryStomachGastroenterologyProton Pump InhibitorsGastric Acidity DeterminationMiddle AgedHelicobacter pyloribiology.organism_classificationCrossover studyCircadian Rhythmmedicine.anatomical_structureDuodenal UlcerDuodenumFemalebusinessOmeprazolemedicine.drugAlimentary Pharmacology &amp; Therapeutics
researchProduct

Hemodynamic and ventilatory changes during implant surgery with intravenous conscious sedation

2010

Purpose: This study was conducted to determine the hemodynamic and ventilatory changes during implant surgery with intravenous conscious sedation, and whether preoperative anxiety, gender or age influence these parameters. Patients and Methods: A prospective study carried out between May 2004 and February 2007, on 102 patients treated with dental implants under local anesthesia and conscious intravenous sedation. Patients completed a questionnaire prior to surgery to evaluate preoperative dental anxiety using Corah's scale. The hemodynamic and ventilatory changes were evaluated by monitoring systolic pressure (SP), diastolic pressure (DP), heart rate (HR) and oxygen saturation (SaO2). These…

AdultMalemedicine.medical_specialtymedicine.drug_classSedationConscious SedationHemodynamicsBlood PressureFentanylIntraoperative PeriodHeart RateHeart ratemedicineHumansHypnotics and SedativesLocal anesthesiaProspective StudiesGeneral DentistryAgedAged 80 and overLocal anestheticbusiness.industryHemodynamicsMiddle Aged:CIENCIAS MÉDICAS [UNESCO]SurgeryOxygenDental ImplantationBlood pressureOtorhinolaryngologyAnesthesiaInjections IntravenousUNESCO::CIENCIAS MÉDICASMidazolamFemaleSurgerymedicine.symptombusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct